Literature DB >> 32632629

Administration of indigenous probiotics modulate high-fat diet-induced metabolic syndrome in Sprague Dawley rats.

Sakshi Khanna1, Sanisha Walia1, Kanthi Kiran Kondepudi2, Geeta Shukla3.   

Abstract

Modulation of the gut microbiota by probiotics, is emerging as a promising approach for the management of metabolic diseases but due to their species and strain specific response, isolation of new probiotic strains is gaining importance. The present study was designed to assess the effect of isolated and well characterised indigenous probiotics, Lactobacillus pentosus GSSK2, Lactobacillus fermentum PUM and Lactobacillus plantarum GS26A in high fat diet (HFD) induced metabolic syndrome. It was observed that though supplementation of all three probiotics for 12 weeks to Sprague Dawley rats fed with HFD, ameliorated the anthropometric parameters, but L. pentosus GSSK2 showed maximum reduction in weight gain while maximum decrease in abdominal circumference, Lee's index, BMI and visceral fat deposition was observed in L. plantarum GS26A compared with HFD animals. Further, administration of L. plantarum GS26A to HFD animals led to significant increase in lactic acid bacteria count and lipid excretion in feces followed by L. pentosus GSSK2 and L. fermentum PUM compared with counter controls. Additionally, both L. pentosus GSSK2 and L. plantarum GS26A exhibited improved glucose tolerance, liver biomarkers, alleviated oxidative stress and restored the histoarchitechture of adipose tissue, colon and liver compared with HFD animals. The study highlights the prophylactic potential of isolated probiotics in experimental metabolic syndrome model and revealed that amongst all three probiotics, L. pentosus GSSK2 and L. plantarum GS26A were equally effective and more promising than L. fermentum PUM in improving metabolic dysfunctions and may be employed as functional foods but needs to be correlated clinically.

Entities:  

Keywords:  Dyslipidemia; High fat diet; Metabolic syndrome; Obesity; Probiotics

Mesh:

Substances:

Year:  2020        PMID: 32632629     DOI: 10.1007/s10482-020-01445-y

Source DB:  PubMed          Journal:  Antonie Van Leeuwenhoek        ISSN: 0003-6072            Impact factor:   2.271


  5 in total

1.  Probiotic activity traits in vitro and production of antimicrobial peptides by Lactobacillaceae isolates from pulque using Lactobacillus acidophilus NCFM as control.

Authors:  Yesica Ruíz-Ramírez; Paula Cecilia Guadarrama-Mendoza; Adelfo Escalante; Martha Giles-Gómez; Rogelio Valadez-Blanco
Journal:  Braz J Microbiol       Date:  2022-01-29       Impact factor: 2.214

Review 2.  Limosilactobacillus fermentum, Current Evidence on the Antioxidant Properties and Opportunities to be Exploited as a Probiotic Microorganism.

Authors:  Luciana Caroline Paulino do Nascimento; Diego Cabral Lacerda; Diorginis José Soares Ferreira; Evandro Leite de Souza; José Luiz de Brito Alves
Journal:  Probiotics Antimicrob Proteins       Date:  2022-04-25       Impact factor: 5.265

3.  Probiotics counteract hepatic steatosis caused by ketogenic diet and upregulate AMPK signaling in a model of infantile epilepsy.

Authors:  Chunlong Mu; Naghmeh Nikpoor; Thomas A Tompkins; Jong M Rho; Morris H Scantlebury; Jane Shearer
Journal:  EBioMedicine       Date:  2022-02-09       Impact factor: 8.143

4.  Lactobacillus plantarum S9 alleviates lipid profile, insulin resistance, and inflammation in high-fat diet-induced metabolic syndrome rats.

Authors:  Lei Zhao; Yunjiao Shen; Yunlong Wang; Lei Wang; Lin Zhang; Zijian Zhao; Shengyu Li
Journal:  Sci Rep       Date:  2022-09-15       Impact factor: 4.996

5.  Synbiotic (Lactiplantibacillus pentosus GSSK2 and isomalto-oligosaccharides) supplementation modulates pathophysiology and gut dysbiosis in experimental metabolic syndrome.

Authors:  Sakshi Khanna; Mahendra Bishnoi; Kanthi Kiran Kondepudi; Geeta Shukla
Journal:  Sci Rep       Date:  2021-11-01       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.